Research programme: osteoarthritis therapy - CollaGenex
Alternative Names: Osteoarthritis therapy research programme - CollaGenexLatest Information Update: 04 May 2007
Price :
$50 *
At a glance
- Originator CollaGenex Pharmaceuticals
- Class
- Mechanism of Action Collagenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoarthritis
Most Recent Events
- 04 May 2007 Discontinued - Preclinical for Osteoarthritis in USA (unspecified route)
- 10 Feb 2000 New profile
- 10 Feb 2000 Preclinical development for Osteoarthritis in USA (Unknown route)